PATHWAY-2: Spironolactone for resistant hypertension - Authors' reply

Bryan Williams; Tom M MacDonald; Steven V Morant; Morris J Brown

doi:10.1016/S0140-6736(16)00698-X

PATHWAY-2: Spironolactone for resistant hypertension - Authors' reply

Bryan Williams (Lead / Corresponding author), Tom M MacDonald, Steven V Morant, Morris J Brown

Molecular and Clinical Medicine

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	1373-1374
Number of pages	2
Journal	Lancet
Volume	387
Issue number	10026
DOIs	https://doi.org/10.1016/S0140-6736(16)00698-X
Publication status	Published - 2 Apr 2016

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/S0140-6736(16)00698-X

Cite this

@article{9b33239c2eb2420fa1c90f2433148dff,

title = "PATHWAY-2: Spironolactone for resistant hypertension - Authors' reply",

author = "Bryan Williams and MacDonald, {Tom M} and Morant, {Steven V} and Brown, {Morris J}",

year = "2016",

month = apr,

day = "2",

doi = "10.1016/S0140-6736(16)00698-X",

language = "English",

volume = "387",

pages = "1373--1374",

journal = "Lancet",

issn = "0140-6736",

publisher = "ELSEVIER SCIENCE INC",

number = "10026",

}

TY - JOUR

T1 - PATHWAY-2

T2 - Spironolactone for resistant hypertension - Authors' reply

AU - Williams, Bryan

AU - MacDonald, Tom M

AU - Morant, Steven V

AU - Brown, Morris J

PY - 2016/4/2

Y1 - 2016/4/2

UR - http://www.scopus.com/inward/record.url?scp=84964206618&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(16)00698-X

DO - 10.1016/S0140-6736(16)00698-X

M3 - Letter

AN - SCOPUS:84964206618

SN - 0140-6736

VL - 387

SP - 1373

EP - 1374

JO - Lancet

JF - Lancet

IS - 10026

ER -

PATHWAY-2: Spironolactone for resistant hypertension - Authors' reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this